Talis Biomedical Corp Stock Technical Analysis

TLIS Stock  USD 2.84  0.00  0.00%   
As of the 12th of February 2026, Talis Biomedical has the Risk Adjusted Performance of 0.1091, variance of 91.0, and Coefficient Of Variation of 812.4. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Talis Biomedical Corp, as well as the relationship between them. Please validate Talis Biomedical Corp risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis to decide if Talis Biomedical is priced more or less accurately, providing market reflects its prevalent price of 2.84 per share. Please also confirm Talis Biomedical Corp information ratio, which is currently at 0.1146 to double-check the company can sustain itself at a future point.

Talis Biomedical Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Talis, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Talis
  
Talis Biomedical's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Please note, there is a significant difference between Talis Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Talis Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Talis Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Talis Biomedical 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Talis Biomedical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Talis Biomedical.
0.00
11/14/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/12/2026
0.00
If you would invest  0.00  in Talis Biomedical on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Talis Biomedical Corp or generate 0.0% return on investment in Talis Biomedical over 90 days. Talis Biomedical Corporation operates as a molecular diagnostic company More

Talis Biomedical Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Talis Biomedical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Talis Biomedical Corp upside and downside potential and time the market with a certain degree of confidence.

Talis Biomedical Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Talis Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Talis Biomedical's standard deviation. In reality, there are many statistical measures that can use Talis Biomedical historical prices to predict the future Talis Biomedical's volatility.
Hype
Prediction
LowEstimatedHigh
0.142.8412.68
Details
Intrinsic
Valuation
LowRealHigh
0.132.5312.37
Details

Talis Biomedical February 12, 2026 Technical Indicators

Talis Biomedical Corp Backtested Returns

Talis Biomedical is dangerous given 3 months investment horizon. Talis Biomedical Corp owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.13, which indicates the firm had a 0.13 % return per unit of risk over the last 3 months. We were able to collect and analyze data for sixteen different technical indicators, which can help you to evaluate if expected returns of 1.25% are justified by taking the suggested risk. Use Talis Biomedical Corp Coefficient Of Variation of 812.4, variance of 91.0, and Risk Adjusted Performance of 0.1091 to evaluate company specific risk that cannot be diversified away. Talis Biomedical holds a performance score of 10 on a scale of zero to a hundred. The entity has a beta of -1.0, which indicates a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Talis Biomedical are expected to decrease slowly. On the other hand, during market turmoil, Talis Biomedical is expected to outperform it slightly. Use Talis Biomedical Corp information ratio and rate of daily change , to analyze future returns on Talis Biomedical Corp.

Auto-correlation

    
  0.00  

No correlation between past and present

Talis Biomedical Corp has no correlation between past and present. Overlapping area represents the amount of predictability between Talis Biomedical time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Talis Biomedical Corp price movement. The serial correlation of 0.0 indicates that just 0.0% of current Talis Biomedical price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0
Talis Biomedical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Talis Biomedical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Talis Biomedical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Talis Biomedical Corp Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Talis Biomedical Corp across different markets.

About Talis Biomedical Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Talis Biomedical Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Talis Biomedical Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Talis Biomedical Corp price pattern first instead of the macroeconomic environment surrounding Talis Biomedical Corp. By analyzing Talis Biomedical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Talis Biomedical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Talis Biomedical specific price patterns or momentum indicators. Please read more on our technical analysis page.

Talis Biomedical February 12, 2026 Technical Indicators

Most technical analysis of Talis help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Talis from various momentum indicators to cycle indicators. When you analyze Talis charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Talis Biomedical February 12, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Talis stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Additional Tools for Talis Pink Sheet Analysis

When running Talis Biomedical's price analysis, check to measure Talis Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talis Biomedical is operating at the current time. Most of Talis Biomedical's value examination focuses on studying past and present price action to predict the probability of Talis Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talis Biomedical's price. Additionally, you may evaluate how the addition of Talis Biomedical to your portfolios can decrease your overall portfolio volatility.